MedTech & Diagnostics
PROCEPT BioRobotics Executive Compensation (FY25)
PRCT · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025 ◇ Larry Wood | Latest say-on-pay support = June 9, 2026 | Chief executive pay ratio ◇ To the median employee |
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
The paid brief on PROCEPT BioRobotics
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$500 for the Executive Compensation Report. Both reports for $900.
Data as of November 5, 2026Latest filing (8-K): June 10, 2026
10 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Velarion Intel, one year, every company
279 figures on this page: 274 cited to the filing that reported them, 5 calculated from figures it prints. See the citations
More on PROCEPT BioRobotics
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Reza Zadno → Larry Wood
Say-on-pay support: 95.5% → 73.1% (22.4 points lower)
CEO pay ratio: 38:1 → 132:1 (247.4% higher)
Frequently asked questions
Answers drawn from the data on this page.
Who is PROCEPT BioRobotics' chief executive and what were they paid?
Larry Wood was paid $16,783,853 in total compensation as President & Chief Executive Officer for fiscal 2025.
What was PROCEPT BioRobotics' say-on-pay result?
The say-on-pay proposal drew 73.1% of votes cast for or against in favor at the meeting held June 9, 2026 for fiscal 2025.
Which companies are in PROCEPT BioRobotics' peer group?
The disclosed peer group includes Certara, Inspire Medical Systems, Nevro, OrthoPediatrics and Paragon 28, among others.
What is PROCEPT BioRobotics' chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 132:1, against median employee compensation of $178,612.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Reza Zadno President & Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Kevin Waters EVP, Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Hisham Shiblaq EVP, Chief Commercial Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | — | ◇ |
Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Fiscal 2023
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Reza Zadno Former President & Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Kevin Waters EVP, Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Hisham Shiblaq Former EVP, Chief Commercial Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Reza Zadno Former President & Chief Executive Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Hisham Shiblaq Former EVP, Chief Commercial Officer | ◇ | — | ◇ | ◇ | ◇ | — | — | ◇ |
Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kevin Waters EVP, Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Larry Wood President & Chief Executive Officer | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Reza Zadno Former President & Chief Executive Officer Departed during or after this year | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Kevin Waters EVP, Chief Financial Officer | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Alaleh Nouri EVP, Chief Legal Officer & Corporate Secretary | ◇ | — | ◇ | ◇ | ◇ | — | ◇ | ◇ |
Hisham Shiblaq Former EVP, Chief Commercial Officer Departed during or after this year | ◇ | — | ◇ | ◇ | — | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Alaleh Nouri | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Alaleh Nouri | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Hisham Shiblaq | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Hisham Shiblaq | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Kevin Waters | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Kevin Waters | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
| Larry L. Wood | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Larry L. Wood | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Reza Zadno | OPTION | ◇ | — | — | ◇ | — | ◇ | ◇ |
| Reza Zadno | PSU | ◇ | ◇ | ◇ | ◇ | ◇ | — | ◇ |
Fiscal 2022 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Larry Wood | Option | ◇ | — | ◇ | 9/1/2035 |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 4/17/2034 | |
| Reza Zadno | Option | ◇ | — | ◇ | 2/15/2033 |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/6/2034 | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/30/2032 | |
| Kevin Waters | RSU | ◇ | ◇ | — | — |
| Option | ◇ | — | ◇ | 2/15/2033 | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/6/2034 | |
| RSU | ◇ | = | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/30/2032 | |
| Alaleh Nouri | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 2/15/2033 | |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/6/2034 | |
| RSU | ◇ | = | — | — | |
| PSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Option | ◇ | — | ◇ | 3/30/2032 |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Alaleh Nouri
EVP, Chief Legal Officer & Corporate Secretary · Offer letter
| Severance multiple | ◇ |
| Severance base | ◇ |
| Equity acceleration on change in control | ◇ |
Hisham Shiblaq
Former EVP, Chief Commercial Officer · Change-in-control agreement
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Clawback | ◇ |
Kevin Waters
EVP, Chief Financial Officer · Change-in-control agreement
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Clawback | ◇ |
Larry Wood
President & Chief Executive Officer · Change-in-control agreement
| Severance multiple | ◇ |
| Severance base | ◇ |
| Change-in-control multiple | ◇ |
| Benefits continuation on change in control | ◇ |
| Benefits continuation | ◇ |
| Clawback | ◇ |
Reza Zadno
Former President & Chief Executive Officer
| Equity acceleration on change in control | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Thomas M. Prescott Board chair | ◇ | ◇ | ◇ | — | — | — | ◇ |
Taylor Harris | ◇ | ◇ | ◇ | — | — | — | ◇ |
Elisabeth Little | ◇ | ◇ | ◇ | — | — | — | ◇ |
Amy Dodrill | ◇ | ◇ | ◇ | — | — | — | ◇ |
Antal Desai | ◇ | ◇ | ◇ | — | — | — | ◇ |
Mary Garrett | ◇ | ◇ | ◇ | — | — | — | ◇ |
Frederic Moll, M.D | ◇ | ◇ | ◇ | — | — | — | ◇ |
Daniel Puckett and Larry L. Wood served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board cash retainer | ◇ |
| Board equity retainer | ◇ |
| Total board retainer | ◇ |
| Board chair premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- Certara CERT
- Inspire Medical Systems INSP
- Nevro NVRO
- OrthoPediatrics KIDS
- Paragon 28 FNA
- Penumbra PEN
- Revance Therapeutics RVNC
- RxSight RXST
- Silk Road Medical SILK
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | June 9, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | June 10, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | June 4, 2024 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Ask our research desk — $99, 24h, every figure cited to its filing.
Sample answer — “What is the CEO’s total compensation?”
- Reza Zadno (Former President & Chief Executive Officer), FY2025 total compensation $6,766,276 (base salary $471,306) [exec_comp, SEC accession 0001588978-26-000017, filed 2026-04-22]What this page does not include
Everything above is a fact PROCEPT BioRobotics disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where PROCEPT BioRobotics sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
279 figures on this page: 274 cited to the filing that reported them, 5 calculated from figures it prints.
274 cited to the filing
5 calculated from the filing
Documents cited
- 0001588978-26-000026Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote: Votes For Vot
- 0001588978-26-000017Chief Executive Officer Pay Ratio · Director Compensation in 2025 · Grants of Plan-Based Awards · NON-EMPLOYEE DIRECTOR COMPENSATION · and 1 more section
- 0001588978-25-000038Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote: Votes For Vot
- 0001588978-25-000028Summary Compensation Table
- 0001628280-24-026712Proposal 3 in the Proxy Statement, a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, was approved by the following vote: Votes For Vot
- 0001628280-24-017167Summary Compensation Table
- 0001628280-23-013251
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “PROCEPT BioRobotics executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/PRCT (accessed 2026).
Short form: data: Velarion
The paid brief for PROCEPT BioRobotics
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
$500 for the Executive Compensation Report. Both reports for $900.
10 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about PROCEPT BioRobotics and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
MedTech & Diagnostics rankings
Peers PROCEPT BioRobotics discloses
The companies named in PRCT's own disclosed peer group.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}